Hepatitis E in High-Income Countries: What Do We Know? And What Are the Knowledge Gaps?

被引:26
|
作者
Capai, Lisandru [1 ]
Charrel, Remi [2 ]
Falchi, Alessandra [1 ]
机构
[1] Univ Corse, INSERM, Lab Virol, BIOSCOPE EA7310, F-20250 Corte, France
[2] Aix Marseille Univ, UVE, INSERM 1207, IHU Mediterranee Infect,IRD 190, F-13005 Marseille, France
来源
VIRUSES-BASEL | 2018年 / 10卷 / 06期
关键词
Hepatitis E virus; clinical; transmission; zoonosis; virology; E VIRUS-INFECTION; NON-B-HEPATITIS; ENTERS LIVER-CELLS; TRANSMITTED NON-A; 1ST CASE-REPORT; RAW PORK LIVER; BLOOD-DONORS; GENOTYPE; VIRAL-HEPATITIS; ORF3; PROTEIN;
D O I
10.3390/v10060285
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Hepatitis E virus (HEV) is a positive-strand RNA virus transmitted by the fecal-oral route. HEV genotypes 1 and 2 infect only humans and cause mainly waterborne outbreaks. HEV genotypes 3 and 4 are widely represented in the animal kingdom, and are mainly transmitted as a zoonosis. For the past 20 years, HEV infection has been considered an imported disease in developed countries, but now there is evidence that HEV is an underrecognized pathogen in high-income countries, and that the incidence of confirmed cases has been steadily increasing over the last decade. In this review, we describe current knowledge about the molecular biology of HEV, its clinical features, its main routes of transmission, and possible therapeutic strategies in developed countries.
引用
收藏
页数:23
相关论文
共 50 条
  • [11] We know what they think, but do we know what they do?
    Callingham, M
    Baker, T
    INTERNATIONAL JOURNAL OF MARKET RESEARCH, 2002, 44 (03) : 299 - 335
  • [12] What do we know? What do we need to know?
    Milena J. Henzlova
    W. Lane Duvall
    Journal of Nuclear Cardiology, 2017, 24 : 252 - 254
  • [13] What do we know? What do we need to know?
    Henzlova, Milena J.
    Duvall, W. Lane
    JOURNAL OF NUCLEAR CARDIOLOGY, 2017, 24 (01) : 252 - 254
  • [14] Quasicrystals: What do we know? What do we want to know? What can we know?
    Steurer, Walter
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2018, 74 : 1 - 11
  • [15] THE NATIONAL INCOME, AND WHAT DO WE KNOW ABOUT IT?
    Stine, O. C.
    JOURNAL OF FARM ECONOMICS, 1936, 18 (04): : 745 - 747
  • [16] Pediatric medication errors: What do we know? What gaps remain?
    Kaushal, R
    Jaggi, T
    Walsh, K
    Fortescue, EB
    Bates, DW
    AMBULATORY PEDIATRICS, 2004, 4 (01) : 73 - 81
  • [17] Industrial Clusters and Corporate Social Responsibility in Developing Countries: What We Know, What We do not Know, and What We Need to Know
    Peter Lund-Thomsen
    Adam Lindgreen
    Joelle Vanhamme
    Journal of Business Ethics, 2016, 133 : 9 - 24
  • [18] Industrial Clusters and Corporate Social Responsibility in Developing Countries: What We Know, What We do not Know, and What We Need to Know
    Lund-Thomsen, Peter
    Lindgreen, Adam
    Vanhamme, Joelle
    JOURNAL OF BUSINESS ETHICS, 2016, 133 (01) : 9 - 24
  • [19] Experience of targeting subsidies on insecticide-treated nets: what do we know and what are the knowledge gaps?
    Worrall, E
    Hill, J
    Webster, J
    Mortimer, J
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2005, 10 (01) : 19 - 31
  • [20] Chronic prostatitis: what we know, what we do not know, and what we should do!
    Lobel, B
    Rodriguez, A
    WORLD JOURNAL OF UROLOGY, 2003, 21 (02) : 57 - 63